NovaQuest launches unusual "pharma" fund targeting $750 mln

NovaQuest Capital Management is back in the market with its fourth fund, seeking $750 million to invest directly in the development of new drugs.

6 November 2014•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.